CClinicalTrials.gg
CompletedNCT00178308Updated Sep 11, 2006

Measuring Alterations of DNA in Human Blood

An observational study in Neoplasms, sponsored by University of Rochester. Completed at 1 site in United States. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2006-09-11.

Sponsored by University of Rochester · Observational

Study type
Observational
Model
Defined population
Time perspective
Prospective
Enrollment
24
Ages
21 Years to 70 Years
Sex
All
01

Study summary

The purpose of this research is to evaluate an automated, laser-based technique for measuring DNA damge resulting from radiation. We want to use controlled exposure on cancer patients to help develop a measurement to test people who may have been accidentally exposed to radiation.

02

Conditions studied

  • Neoplasms
03

In context

Lead sponsor

University of Rochester is the lead sponsor of 715 studies on the registry; 116 are open to participants now.

Of its 56 completed or terminated interventional studies of FDA-regulated products, 44 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All

Eligibility criteria

Inclusion Criteria:

  • Male or female, age 21 to 70 years old.
  • Patient undergoing with anti-neoplastic agent(s) known to have genotoxic activity (e.g., cyclophosphamide, 5-FU, cisplatin, Ara-C.
  • X-irradiation may be considered, so long as a substantial fraction of red marrow is exposed (e.g., femur or chest/trunk region);
  • treatment could be ongoing therapy or initial therapy.
05

Study design

Observational model
Defined population
Time perspective
Prospective
Enrollment
24 participants
06

Study locations

1 site
  • University of Rochester
    Rochester, New York, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00178308
Lead sponsor
University of Rochester
Collaborators
Litron Laboratories
First posted
Sep 15, 2005
Last update
Sep 11, 2006

Study contacts

Yuhchyau Chen, MD, Ph.D
principal investigator · Universtiy of Rochester, Dept of Radiation Oncology
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion